Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Telangana Medical Devices Park to be launched on June 17

      Telangana Medical Devices Park to be launched on June 17

      Ruby Khatun Khatun8 Jun 2017 1:27 PM IST
      'Telangana Medical Devices Park', a dedicated ecosystem for MedTech innovation and manufacturing will be launched at Sultanpur village in Medak...
      AstraZeneca sells migraine drug for up to 302 million dollar

      AstraZeneca sells migraine drug for up to 302 million dollar

      Ruby Khatun Khatun8 Jun 2017 1:23 PM IST
      AstraZeneca continued its program of divesting old medicines on Wednesday with the sale for up to $302 million of migraine drug Zomig to Germany's...
      AbbVies rheumatoid arthritis drug succeeds in trial

      AbbVie's rheumatoid arthritis drug succeeds in trial

      Ruby Khatun Khatun8 Jun 2017 9:27 AM IST
      AbbVie Inc said on Wednesday its oral rheumatoid arthritis drug succeeded in a late-stage study on patients who had not adequately responded to...
      4 more medical devices to be added to price control list, document shows

      4 more medical devices to be added to price control list, document shows

      Ruby Khatun Khatun7 Jun 2017 1:36 PM IST
      New Delhi/Mumbai: India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for...
      Alembic Pharma looks to file 100 ANDAs in US in next 3 yrs

      Alembic Pharma looks to file 100 ANDAs in US in next 3 yrs

      Ruby Khatun Khatun7 Jun 2017 1:33 PM IST
      Drug firm Alembic Pharmaceuticals is looking at filing 100 abbreviated new drug applications with the US health regulator over the next three years...
      Dr Reddy

      Dr Reddy's Laboratories Announces Launch of Bivalirudin for Injection in US Market

      Ruby Khatun Khatun7 Jun 2017 1:32 PM IST
      Hyderabad & Princeton: Dr. Reddy’s Laboratories Ltd. announced that it has launched Bivalirudin for Injection, 250 mg/vial, a therapeutic...
      Unichem Lab gets EIR from USFDA for Ghaziabad formulation unit

      Unichem Lab gets EIR from USFDA for Ghaziabad formulation unit

      Ruby Khatun Khatun7 Jun 2017 1:32 PM IST
      Drug firm Unichem Laboratories said it has received an establishment inspection report from the US health regulator for its formulation manufacturing...
      Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy

      Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy

      Ruby Khatun Khatun7 Jun 2017 1:32 PM IST
      NEW YORK: Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to tafamidis, the company’s...
      Credit Suisse hires Rapkin for healthcare investment banking

      Credit Suisse hires Rapkin for healthcare investment banking

      Ruby Khatun Khatun7 Jun 2017 9:39 AM IST
      Credit Suisse Group AG has hired Cory Rapkin as vice chairman in the healthcare group of its investment banking and capital markets division,...
      Pfizer drug delays lung cancer growth longer than Astras Iressa-study

      Pfizer drug delays lung cancer growth longer than Astra's Iressa-study

      Ruby Khatun Khatun7 Jun 2017 9:08 AM IST
      A targeted drug being developed by Pfizer Inc held advanced lung cancer in check longer than AstraZeneca's Iressa in newly diagnosed patients, but...
      FDA expands use of Sapien 3 artificial heart valve for high-risk patients

      FDA expands use of Sapien 3 artificial heart valve for high-risk patients

      Ruby Khatun Khatun6 Jun 2017 12:24 PM IST
      The U.S. Food and Drug Administration approved an expanded indication for the Sapien 3 Transcatheter Heart Valve (THV) for patients with symptomatic...
      IIT-Kharagpur New tech that helps doctors monitor patiently remotely

      IIT-Kharagpur New tech that helps doctors monitor patiently remotely

      Ruby Khatun Khatun6 Jun 2017 12:22 PM IST
      Kolkata: IIT-Kharagpur has come up with a life-saver technology that can be fitted in an ambulance to ensure remote monitoring of the condition of a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok